Dear All, thank you very much for filling in the doodle.
We'll have the next TC on Thursday 26th April at 11am
Date and time
Thursday 26th April at 11am
Ready-Access Number:
900800678
Secondary Ready-Access Number:
+34 917911859
7-Digit Access Code:
3160100
Tentative agenda:
- status of the data
- updates from the analysis group meeting
- analysis plans
- Biology of Genomes poster draft
- future meetings
The next Analysis meeting will take place in Barcelona and anyone interested is welcome to join,
here is the doodle for the next meeting: http://www.doodle.com/z7a3mq92b9syz9xg
Conference code:
Best,
Tuuli and Gabrielle
Gabrielle Bertier
Scientific Project Manager
International Collaboration Office
CRG, Center for Genomic Regulation
Carrer Dr. Aiguader, 88
08003 Barcelona, España
Tel: +34933160374
Mobile: +34639960656
email: gabrielle.bertier(a)crg.es<mailto:gabrielle.bertier@crg.es>
web: www.geuvadis.eu
From: geuvadis_wpl-bounces(a)lists.crg.es [mailto:geuvadis_wpl-bounces@lists.crg.es] On Behalf Of Tuuli Lappalainen
Sent: 17 April, 2012 5:22 PM
Cc: geuvadis_rnaseq(a)lists.crg.es; geuvadis_wpl(a)lists.crg.es
Subject: Re: [Geuvadis_wpl] GEUVADIS RNAseq General Update
Dear all,
Please fill in the Doodle for a TC with the whole Geuvadis RNAseq group by Wednesday noon.
best regards,
Tuuli
Tuuli Lappalainen, PhD
Department of Genetic Medicine and Development
University of Geneva Medical School
CMU / Rue Michel-Servet 1
1211 Geneva 4
Switzerland
Tel. +41-(0)22-3795550
tuuli.lappalainen(a)unige.ch<mailto:tuuli.lappalainen@unige.ch>
On 4/12/12 11:10 AM, Gabrielle Anne Bertier wrote:
Dear all,
At the request of Tuuli, please fill in the doodle<http://doodle.com/3i5f4wt28ez596sx> to schedule a TC with the whole RNAseq group for an update on the data analysis.
Tentative agenda:
- status of the data
- updates from the analysis group meeting
- analysis plans
- Biology of Genomes poster draft
- future meetings
Kind regards,
Gabrielle
doodle full link: http://doodle.com/3i5f4wt28ez596sx
Gabrielle Bertier
Scientific Project Manager
International Collaboration Office
CRG, Center for Genomic Regulation
Carrer Dr. Aiguader, 88
08003 Barcelona, España
Tel: +34933160374
Mobile: +34639960656
email: gabrielle.bertier(a)crg.es<mailto:gabrielle.bertier@crg.es>
web: www.geuvadis.eu
_______________________________________________
Geuvadis_wpl mailing list
Geuvadis_wpl(a)lists.crg.es<mailto:Geuvadis_wpl@lists.crg.es>
http://davinci.crg.es/mailman/listinfo/geuvadis_wpl
Dear all,
The next Geuvadis analysis group meeting will take place in Barcelona in
late June or early July. If you'd be interested in attending, please
fill the Doodle to find the best time for the 2-day meeting:
http://www.doodle.com/z7a3mq92b9syz9xg
best regards,
Tuuli
--
Tuuli Lappalainen, PhD
Department of Genetic Medicine and Development
University of Geneva Medical School
CMU / Rue Michel-Servet 1
1211 Geneva 4
Switzerland
Tel. +41-(0)22-3795550
tuuli.lappalainen(a)unige.ch
Hi all,
Here are some slides from the GEM-bwa comparison. 5 samples were mapped
with the two mappers, and I analyzed mapping statistics, exon
quantifications and allelic ratios. As expected, GEM maps a lot more
reads than bwa, and seems to perform very well also otherwise.
We can discuss this (and other things) on Thursday's analysis group call
(2pm) - I'll send the call details later.
best regards,
Tuuli
--
Tuuli Lappalainen, PhD
Department of Genetic Medicine and Development
University of Geneva Medical School
CMU / Rue Michel-Servet 1
1211 Geneva 4
Switzerland
Tel. +41-(0)22-3795550
tuuli.lappalainen(a)unige.ch
Dear all,
I've updated and reorganized the Geuvadis RNAseq ftp site and wiki.
The ftp site now has the following data available (among some additional
things):
- fastq freezes of both mRNA and miRNA
- bwa bam files of all the mRNA data
- exon read counts based on bwa mapping
- genotypes of the phase1 samples (that don't need imputation)
- functional annotation of the genetic variants
- sample information sheets and lists of problematic mRNA samples
- ASE results with variant annotations (this lacks documentation for now
though)
Please see the wiki (Data storage section) for further information of
the contents of the wiki - those of you uploading data to the ftp,
please keep this section of the wiki up to date. The wiki has
documentation of what has been done thus far, methods, practical
informations and e.g. examples of how to use Aspera, and other
information (such as the analysis plan).
I'll be in touch with some of you to add data and/or documentation.
best regards,
Tuuli
--
Tuuli Lappalainen, PhD
Department of Genetic Medicine and Development
University of Geneva Medical School
CMU / Rue Michel-Servet 1
1211 Geneva 4
Switzerland
Tel. +41-(0)22-3795550
tuuli.lappalainen(a)unige.ch
Dear all,
Here are the minutes of the Geuvadis analysis group TC of Thursday 5th
of April. Apologies for the long email, it's been 2 hectic weeks of data
processing and we went through a lot of things:
Fastq files:
- All the labs have uploaded mRNA and miRNA fastqs, except for 48 miRNA
samples from Kiel where sequencing was delayed, and a few failed miRNA
samples that will be skipped. Checksums are OK.
- Kiel will sequence the missing miRNA samples next week
- Thasso discovered that labs 2,3,6,7 produced fastq files without reads
that fail Illumina quality checks, whereas 1,4,5 had them included - in
order to be uniform, they should be filtered from all which has been
done by Natalja & Tuuli. Two labs submitted 50bp miRNA reads and Tuuli
clipped them. All the new files have been uploaded to the ftp site.
- Next week the final set of filtered files, checksums and sample
metadata will be put under clear ftp directories as the first raw data
freeze - this will still be without more refined QC filters.
mRNA data processing
- GEM BAM files had format issues and need to be recreated. This is
being run for the sandbox dataset, and Tuuli will check that this
version is fine before rest of the data is processed.
- In order to proceed with the analysis in the meanwhile, Tuuli is
finishing mapping with bwa and will start submitting these bams too. The
first eQTL and ASE analysis will be based on bwa.
- All the mapping result files that were based on nonfiltered data from
labs 1,4,5 need to be filtered afterwards - Tuuli and Thasso have taken
care of this.
- Micha will upload transcript quantifications (RPKM and read counts) to
the ftp site, and Tuuli will upload exon read counts - these will happen
within a week.
- According to Ivo, they are planning to submit the GEM manuscript next
week.
miRNA data processing
- Marc F. has downloaded all the fastqs and started running the first
steps of their miRNA pipeline. The basic analysis should be done in 1-2
weeks.
Genotypes
- Of our 465 samples, 42 are not in 1000g Phase1 dataset and have to be
imputed from 2.5M Omni genotypes. Natalja and Thomas W. from Munich had
done this in parallel using Impute2. However, Tuuli detected a serious
problem in the results - for some reason the imputation quality scores
and the allele frequencies are very bad. The imputation will need to be
debugged and redone. Tuuli, Thomas and Natalja will look into this next
week. The good news is that we can do analysis for now using just the
423 Phase1 samples.
Analysis group meeting in Geneva
- 19 people will attending. Tuuli presented a draft of the program -
first day brainstorming and presentations from all the labs, second day
of building a concrete analysis plan with responsibilities and deadlines.
Biology of Genomes meeting at Cold Spring Harbor
- We got a poster presentation - which is not a bad thing considering
the timeline, the meeting is 4.5 weeks.
- We went briefly through some main analysis items that we can get done
by then at least as first versions: eQTLs and their annotations, ASE,
loss-of-function variants, splicing variation, quantitative/qualitative
gene expression variation, miRNA variation and miRNA-mRNA correlation,
unannotated transcripts... It will be a very nice poster if we work hard.
Collaboration with Daniel McArthur (from Boston, previously at Sanger)
- Dan is a loss-of-function specialist who has expressed interest in
being a collaborator in Geuvadis. We already have analysts who will be
working with LoFs and we should make sure that Daniel would do analysis
that overlaps with this. However, his expertise in calling putative LoF
variants from the 1000g data and pruning out false genotype calls could
give us a good additional resource. People were generally positive about
including him, and Tuuli will discuss with him in more detail what his
interests and contribution would be.
That's all for now - happy Easter to everyone!
best regards,
Tuuli
--
Tuuli Lappalainen, PhD
Department of Genetic Medicine and Development
University of Geneva Medical School
CMU / Rue Michel-Servet 1
1211 Geneva 4
Switzerland
Tel. +41-(0)22-3795550
tuuli.lappalainen(a)unige.ch
Tuuli Lappalainen, PhD
Department of Genetic Medicine and Development
University of Geneva Medical School
CMU / Rue Michel-Servet 1
1211 Geneva 4
Switzerland
Tel. +41-(0)22-3795550
tuuli.lappalainen(a)unige.ch
-------- Original Message --------
Subject: Geuvadis analysis group meeting in Geneva
Date: Thu, 05 Apr 2012 11:28:49 +0200
From: Tuuli Lappalainen <Tuuli.Lappalainen(a)unige.ch>
To: Tuuli.Lappalainen(a)unige.ch, gabrielle.bertier(a)crg.es,
olof.karlberg(a)medsci.uu.se, jean.monlong(a)crg.eu, p.a.c.hoen(a)lumc.nl,
i.pulyakhina(a)lumc.nl, jonas.carlsson(a)medsci.uu.se, esther.lizano(a)crg.eu,
natalja(a)ebi.ac.uk, pedro.ferreira(a)crg.es, marc.friedlaender(a)crg.eu,
r.haesler(a)mucosa.de, m.barann(a)ikmb.uni-kiel.de,
timstrom(a)helmholtz-muenchen.de, thomas.wieland(a)helmholtz-muenchen.de,
thomas.schwarzmayr(a)helmholtz-muenchen.de, sultan(a)molgen.mpg.de,
micha(a)sammeth.net, rivas(a)broadinstitute.org
CC: Ancilla Stefani <Ancilla.Stefani(a)unige.ch>
Hello,
Thank you for registering for the Geuvadis analysis group meeting. We'll
be 20 people in total, and I'm sure it will be a very productive meeting!
Some accommodation practicalities: Hotel Bel Esperance had some rooms
available after all, so we decided to accommodate 4 people there - thus
far we put Esther, Marc F., Peter and Irina there, but if you prefer
Adriatica we can change this. If someone doesn't have accommodation
arranged yet: we have one extra room booked at Bel Esperance, and we can
give this to you if you let me and/or our admin assistant Ancilla
(ancilla.stefani(a)unige.ch) know by April 11.
The program draft is below, and we'll discuss it on the analysis group
TC today. Please let me know if you have schedule conflicts or other
suggestions. This is an informal meeting, so we can also change the
times on the fly if needed.
I will send a document with the final program and info on practicalities
this weekend.
best regards,
Tuuli
Monday, April 16
11 -12 am Geuvadis RNAseq project: Background, aims and data
12 am -12:30 pm Lunch
12:30 -- 2:30pm Presentation by the labs: Ideas, interests, analysis
plans and approaches. 10-25 min each + discussion
Geneva
CNAG
Oxford
EBI
2:30 -3 pm Coffee
3 -5 pm Presentation by the labs:
Kiel
Munich
CRG
Leiden
Uppsala
Berlin
5 - 5:30 pm Wrap-up
8 pm Dinner at Restaurant Demi-Lune
Tuesday, April 17
9 -11:30 am Building an analysis plan
11:30 -12:30 am Lunch
12:30 -- 2:30 pm Building an analysis plan
2:30 -- 3 pm Coffee
3 -- 3:30 pm Wrap-up
Questions for Tuesday:
-What are the essential analyses that must be done? What else will we
do? What are the high-priority analyses?
-How do we integrate the different data types?
-What kind of data types/formats are needed for the analyses? Sharing of
tools and data?
-Who will take the lead of each analysis module? Who else wants to be
involved/informed?
-What are the analyses to do for the Biology of Genomes poster?
-Timelines and deadlines
-Future meetings
-Communication: TCs, mailing lists, wiki, skype
--
Tuuli Lappalainen, PhD
Department of Genetic Medicine and Development
University of Geneva Medical School
CMU / Rue Michel-Servet 1
1211 Geneva 4
Switzerland
Tel. +41-(0)22-3795550
tuuli.lappalainen(a)unige.ch
The call passcode doesn't work for me. Was everyone else able to connect?
Tuuli
--
Tuuli Lappalainen, PhD
Department of Genetic Medicine and Development
University of Geneva Medical School
CMU / Rue Michel-Servet 1
1211 Geneva 4
Switzerland
Tel. +41-(0)22-3795550
tuuli.lappalainen(a)unige.ch
Dear all,
We'll have a Geuvadis RNAseq analysis group call on Thursday April 5th
at 2pm.
Before the call, I'd like to ask you to think what type of data you will
need for the first analyses of the Geuvadis RNAseq data. We are very
close to finishing data freezes for analysis, and now is the point to
identify if additional data types/formats are necessary, and see what
can be done to provide these data.
On the agenda:
- data processing: mRNA, miRNA, sample metadata, genotypes
- analysis group meeting program and practicalities (I will send a
program draft later)
- drafting the outline for the poster/talk at the Biology of Genomes meeting
- collaboration with Daniel McArthur
best regards,
Tuuli
The call details:
Spain 902 125 136
Other countries +34 91 495 18 99
Participants’ Pin-code: 764989*
--
Tuuli Lappalainen, PhD
Department of Genetic Medicine and Development
University of Geneva Medical School
CMU / Rue Michel-Servet 1
1211 Geneva 4
Switzerland
Tel. +41-(0)22-3795550
tuuli.lappalainen(a)unige.ch